Skadden, Kirkland advise on Chinese biotech firm’s $451 million HK IPO

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom and Zhong Lun Law Firm have advised China’s Everest Medicines on its $451 million IPO in Hong Kong, with Kirkland & Ellis and Tian Yuan Law Firm advising the joint sponsors and underwriters.

Asia Deals: Week of October 12

BY Rowena Muñiz |

Latham and Skadden on $6 bln game streaming firms’ merger, Nishimura on Blackstone’s $2.3 bln pharma acquisition, and much more in this week’s Asia Deals roundup

Davis Polk, CAM advise India’s Reliance on sale of $2.6 bln of stakes in retail unit

BY Aparna Sai |

Davis Polk & Wardwell and Cyril Amarchand Mangaldas have advised Reliance Industries on its $2.6 billion sale of stakes in its retail unit to Singapore sovereign wealth fund GIC, global private equity firm TPG Capital, Abu Dhabi Investment Authority (ADIA) and Mubadala Investment Company.

Skadden, Kirkland act on Chinese biopharma firm’s $371 mln HK IPO

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom has advised Shanghai-based biopharmaceutical company JHBP (CY) Holdings, a holding company for Genor Biopharma,  on its HK $2.87 billion ($371 million) IPO in Hong Kong, with Kirkland & Ellis representing the joint sponsors and the underwriters.

Asia Deals: Week of October 5

BY Rowena Muñiz |

JSA on DXC Technology's $5 bln deal with Veritas, host of firms on Offshore Bridge Facility's $1.75 billion take-private, and much more in this week's Asia Deals roundup.

Orrick advises as Japan’s NTT takes mobile unit Docomo private

BY Aparna Sai |

U.S. law firm Orrick, Herrington & Sutcliffe has advised Japan's largest mobile phone operator Docomo, publicly listed some 28 years ago, on a 4.25 trillion yen ($40 billion) tender offer by its parent company NTT to take it private.

Davis Polk, Freshies lead on Chinese software provider’s $797 mln HK IPO

BY Aparna Sai |

Davis Polk & Wardwell has advised Ming Yuan Cloud Group on its HK$6.2 billion ($797 million) IPO on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer representing the joint sponsors and underwriters.

Cleary, Freshies lead on Chinese hotel operator’s $783 mln HK secondary listing

BY Aparna Sai |

Cleary Gottlieb Steen & Hamilton and JunHe have advised Chinese hotel management company Huazhu Group on its $783 million secondary listing on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and Jingtian & Gongcheng representing the underwriters.

Asia Deals: Week of September 28

BY Rowena Muñiz |

Orrick on Docomo’s $40 bln take-private, Skadden on Hitachi Capital's $13.2 bln deal with MUFJ, and much more in this week’s Asia Deals roundup.

Skadden, Freshfields act on ZTO’s $1.55 bln HK secondary listing

BY Aparna Sai |

Skadden, Arps, Slate, Meagher & Flom and Global Law Office Shanghai have advised Chinese courier ZTO Express on its $1.55 billion secondary listing on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and JunHe counselling the sponsor and the underwriters.

Davis Polk, STB advise on pharma firm’s $761 mln HK secondary listing

BY Aparna Sai |

Davis Polk & Wardwell, Zhong Lun Law Firm and have advised Chinese biopharmaceutical company Zai Lab’s on its $761 million secondary listing on the mainboard of the Hong Kong Stock Exchange, with Simpson Thacher & Bartlett and Commerce & Finance Law Offices advising the underwriters.

Slaughters, A&G advise on Aviva’s $1.98 bln sale of SG business

BY Aparna Sai |

Slaughter and May has advised British insurer Aviva on the S$2.7 billion ($1.98 billion) sale of majority shares in its Singapore business to a consortium led by Singapore Life (Singlife). Allen & Gledhill advised on the Singapore law aspects of the transaction.